Comparison of ophthalmic surgery rates in teprotumumab-treated vs. teprotumumab-untreated thyroid eye disease patients

Related authors

• Taylor J. Linaburg
• Tejus Pradeep
• Brian Rinelli
• Yuanyuan Chen
• Yineng Chen
• Gui-Shuang Ying
• César A. Briceño
• Madhura Tamhankar

Related articles

• Quality of life in patients with Graves’ orbitopathy submitted to orbital decompression: comparison between balanced and inferomedial techniques
• Apical bleeding: a rare cause of blindness after orbital decompression
• Multiple evanescent white dot syndrome (MEWDS) following inactivated COVID-19 vaccination (Sinovac-CoronaVac)
• Evaluation of the impact of subepithelial corneal infiltrates on corneal biomechanics after epidemic keratoconjunctivitis
• Trends in Graves’ orbitopathy research in the past two decades: a bibliometric analysis
• Different formulations of corticosteroid eye drops at different treatment times in the control of inflammation and prevention of cystoid macular edema after cataract surgery: randomized clinical trial
• Epidemiology of orbital diseases in a tertiary ophthalmic outpatient clinic in Sao Paulo, Brazil
• Adverse effects associated with peribulbar injection of triamcinolone for the treatment of thyroid eye disease: a retrospective case series
• Evaluation of retinal nerve fiber and ganglion cell layer abnormalities using optical coherence tomography in thyroid-associated orbitopathy
• Lacrimal gland enlargement in inactive thyroid eye disease: a case series and literature review

Click here to search